ArticleBMJ open quality2025
Regional differences in experiences of patients with metastatic breast cancer in the Republic of Ireland and Northern Ireland: a comparative analysis (CTRIAL-IE 23-05).
Article in BMJ open quality, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionMetastatic breast cancer (MBC) presents significant psychological, social and financial challenges. Differences in the healthcare systems of the Republic of Ireland (ROI) and Northern Ireland (NI) may impact patient care experiences. This study aimed to explore regional differences in the experiences of patients with MBC between ROI and NI.
methodsA patient-developed cross-sectional survey titled 'Patient-led Metastatic Breast Cancer Survey' was administered online to patients with MBC in ROI and NI from July to October 2023. The survey included 76 questions addressing demographics, understanding of diagnosis, mental health, financial burden, time spent managing cancer care (time toxicity), palliative care, sexual health, exercise and access to information. These topics were selected by patients with MBC as being most impactful. Responses from 246 patients (196 ROI, 50 NI) were analysed using descriptive and comparative statistics.
resultsPsychological distress was highly prevalent in both regions; however, NI patients were more likely to receive medications for psychological distress (51% NI vs 23.7% ROI, p=0.0008). Financial strain was more pronounced in ROI, with 77.5% feeling they had no control over their medical care spending, compared with 56% of NI patients (p=0.0124). Time toxicity was also higher in ROI, where patients reported more frequent visits to oncology day wards and acute oncology service units (p=0.0012) and spent more time in these settings (p=0.038). Participation in exercise programmes was significantly higher in NI compared with ROI (p<0.0001). Additionally, palliative care referrals were more commonly accepted or considered in NI than in ROI.
conclusionsThis study, the first of its kind, highlights important disparities observed in this cohort of patients with MBC across ROI and NI. Bidirectional learning could enhance patient care experiences, with NI potentially focusing on psycho-oncology integration and ROI expanding strategies to reduce time toxicity and financial burden for patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.